pioglitazone has been researched along with Aortic Aneurysm, Abdominal in 4 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Aortic Aneurysm, Abdominal: An abnormal balloon- or sac-like dilatation in the wall of the ABDOMINAL AORTA which gives rise to the visceral, the parietal, and the terminal (iliac) branches below the aortic hiatus at the diaphragm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Peroxisome proliferator-activated receptor x03B3; agonists have been shown to inhibit angiotensin II (AngII)-induced experimental abdominal aortic aneurysms." | 3.81 | Pioglitazone Identifies a New Target for Aneurysm Treatment: Role of Egr1 in an Experimental Murine Model of Aortic Aneurysm. ( Charolidi, N; Cockerill, GW; Laing, K; Nohturfft, A; Pearce, S; Pirianov, G; Torsney, E, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pini, R | 1 |
| Ciavarella, C | 1 |
| Faggioli, G | 1 |
| Gallitto, E | 1 |
| Indelicato, G | 1 |
| Fenelli, C | 1 |
| Mascoli, C | 1 |
| Vacirca, A | 1 |
| Gargiulo, M | 1 |
| Pasquinelli, G | 1 |
| Charolidi, N | 1 |
| Pirianov, G | 2 |
| Torsney, E | 2 |
| Pearce, S | 1 |
| Laing, K | 1 |
| Nohturfft, A | 1 |
| Cockerill, GW | 2 |
| Golledge, J | 1 |
| Cullen, B | 1 |
| Rush, C | 1 |
| Moran, CS | 1 |
| Secomb, E | 1 |
| Wood, F | 1 |
| Daugherty, A | 1 |
| Campbell, JH | 1 |
| Norman, PE | 1 |
1 review available for pioglitazone and Aortic Aneurysm, Abdominal
| Article | Year |
|---|---|
Diabetes as a negative risk factor for abdominal aortic aneurysm - does the disease aetiology or the treatment provide the mechanism of protection?
Topics: Animals; Aortic Aneurysm, Abdominal; Diabetes Mellitus; Humans; Hypoglycemic Agents; Lipoproteins, H | 2013 |
3 other studies available for pioglitazone and Aortic Aneurysm, Abdominal
| Article | Year |
|---|---|
Different Drugs Effect on Mesenchymal Stem Cells Isolated From Abdominal Aortic Aneurysm.
Topics: Aorta, Abdominal; Aortic Aneurysm, Abdominal; Cell Separation; Cell Survival; Cells, Cultured; Doxyc | 2020 |
Pioglitazone Identifies a New Target for Aneurysm Treatment: Role of Egr1 in an Experimental Murine Model of Aortic Aneurysm.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Base Sequence; Binding Sites; Calcium Chloride; | 2015 |
Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Fenofibrate; Immunohistochem | 2010 |